Commerce Department agency proposes eliminating ‘march-in rights’ as a tool to lower drug prices

.Pharmacy

Jan 11

Written By Ron Andruff

pharmacy

Ron Andruff

The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2019

Purdue’s Demise Could Be A New Beginning For The Pharmaceutical Industry